Real‐world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower‐risk myelodysplastic syndromes

INTRODUCTION: The presence of ring sideroblasts (RS) and mutation of the SF3B1 gene are diagnostic of lower‐risk (LR) myelodysplastic syndromes (MDS) and are correlated with favorable outcomes. However, information on testing and reporting in community‐based clinical settings is scarce. This study f...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Jay L., Abedi, Mehrdad, Cogle, Christopher R., Erba, Harry P., Foucar, Kathryn, Garcia‐Manero, Guillermo, Grinblatt, David L., Komrokji, Rami S., Kurtin, Sandra E., Maciejewski, Jaroslaw P., Pollyea, Daniel A., Revicki, Dennis A., Roboz, Gail J., Savona, Michael R., Scott, Bart L., Sekeres, Mikkael A., Steensma, David P., Thompson, Michael A., Dawn Flick, Elizabeth, Kiselev, Pavel, Louis, Chrystal U., Nifenecker, Melissa, Swern, Arlene S., George, Tracy I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247031/
https://www.ncbi.nlm.nih.gov/pubmed/33220019
http://dx.doi.org/10.1111/ijlh.13400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247031/
https://www.ncbi.nlm.nih.gov/pubmed/33220019
http://dx.doi.org/10.1111/ijlh.13400

Ejemplares similares